• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INOGEN CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INOGEN CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G141
Device Problems Premature Discharge of Battery (1057); Incorrect, Inadequate or Imprecise Result or Readings (1535); Delayed Charge Time (2586); Defective Device (2588); Battery Problem (2885)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/18/2023
Event Type  Injury  
Event Description
It was reported that there was an alert for battery capacity depleted for this cardiac resynchronization therapy defibrillator (crt-d).Device data was preserved and submitted for boston scientific engineering review.Engineering analysis showed that this crt-d experienced 2 consecutive high voltage short lead events followed by end of life (eol).Technical services (ts) recommended replacement of both this crt-d and right ventricular (rv) lead.Then, this patient experienced cardiac arrest and was hospitalized.Upon interrogation a code 1007 was observed, which is indicative of capacitor charge time has exceeded the limit.The charge times were found to be greater than 45 seconds.This patient underwent a surgical procedure in which this crt-d was explanted, and the rv lead remains in service.No additional adverse patient effects were reported.
 
Manufacturer Narrative
This device is expected to be returned and analyzed.A supplemental report will be issued at the time of completion.
 
Event Description
It was reported that there was an alert for battery capacity depleted for this cardiac resynchronization therapy defibrillator (crt-d).Device data was preserved and submitted for boston scientific engineering review.Engineering analysis showed that this crt-d experienced 2 consecutive high voltage short lead events followed by end of life (eol).Technical services (ts) recommended replacement of both this crt-d and right ventricular (rv) lead.Then, this patient experienced cardiac arrest and was hospitalized.Upon interrogation a code 1007 was observed, which is indicative of capacitor charge time has exceeded the limit.The charge times were found to be greater than 45 seconds.This patient underwent a surgical procedure in which this crt-d was explanted, and the rv lead remains in service.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, visual inspection of the device identified an arc mark on the device case.Review of device memory found a shorted lead error code 1004 had been recorded.Memory also showed that after three shocks had been attempted and resulted in abnormal shock impedance measurements, the device battery status moved to end of life (eol) due to long charge times.An x-ray of the device revealed that the internal high voltage fuse was damaged (i.E., no longer intact).The damage to the fuse most likely occurred during delivery of the shock that resulted in the shorted lead error.The damage to the high voltage fuse prevented any subsequent charging of the high voltage capacitors and delivery of shock therapy.As a result, the third high voltage charge attempt caused the device to declare eol because it could not successfully complete charging within 30 seconds, despite the fact that significant battery voltage and capacity remained.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INOGEN CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key16278990
MDR Text Key308567910
Report Number2124215-2023-04131
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526534553
UDI-Public00802526534553
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010012/S341
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/01/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date02/28/2020
Device Model NumberG141
Device Catalogue NumberG141
Device Lot Number126834
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/20/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/13/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age80 YR
Patient SexMale
-
-